risks of glp-1 drugs Use, Risks, and Regulation Know more :https://pib.gov.in/PressReleasePage.aspx?PRID=2247459 Updated Ranking and Side Effects

22 However, the fact that the magnitude and speed of hemoglobin A1c reduction with treatment were identified as risk factors for progression suggests it could be another example of the well-established early worsening phenomenon first observed in type 1 diabetic patients intensively treated with insulin in the Oslo Study, Kroc Collaborative Study and Diabetes Control and Complications Trial

33 Butyrate, a short chain fatty acid that is produced by gut bacteria from fermenting fiber, can stimulate the secretion of GLP-1 from intestinal L-cells

Measuring the correct dose is easy, but so is overmeasuring

Diabetes Metab 42(1):2532

doi: 10.3390/medicina59081459, 7